GlaxoSmithKline reports an eight per cent revenue growth for FY19
The company recently released its consolidated financial results, wherein it reported a 21 per cent hike in net revenue for FY19
Author
Dr Reddy’s to spend up to USD 300 mn on R&D in FY 2019
The R&D spend for the quarter (January-March FY 19) is Rs 366 crore, that is USD 53 million and EBIT 9.19 per cent of the…
AstraZeneca moves US court against Aurobindo Pharma on generic
The AstraZeneca alleged that the Indian drug makers proposed generic Daliresp would infringe the patents on three counts and…
TAKE Solution announces consolidated financial results
The company reported a 28.5 per cent growth in revenues at Rs 20,390 mn and a growth of 11.6 per cent in net profits for FY19;…
Jubilant Life Sciences announces consolidated financial results for Q4 & 12M’FY19 Results
The company reported a 21 per cent hike in YoY total revenue at Rs. 9,111 Crore
Dr Reddy’s Q4 PAT up 44 per cent at Rs 434 crore
The revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same…
Changing brand name mandatory when changing drug composition: CDSCO
The drug regulator stated that the practice of changing the key therapeutic ingredients in a drug formulation without changing the…
Shilpa Medicare gets USFDA nod for cancer drug
The company has received US FDA final approval for its ANDA for Docetaxel Injection USP in the strengths of 20 mg/mL, 80 mg/4 mL…
Biocon and Mylan to announce the final overall survival data for Ogivri
Ogivri is the first biosimilar for Herceptin approved by the US Food and Drug Administration (FDA) for all indications including…
Pfizer’s atopic dermatitis treatment meets goals in late-stage study
The drug developed by the firm, Abrocitinib, was found to have significantly improved clearing of the skin in patients as compared…